MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

SIGA Technologies Inc

Slēgts

SektorsVeselības aprūpe

4.57 -3.99

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.57

Max

4.6899999999999995

Galvenie mērījumi

By Trading Economics

Ienākumi

37M

31M

Pārdošana

1.2M

3.8M

P/E

Sektora vidējais

13.938

63.808

Peļņas marža

802.767

Darbinieki

49

EBITDA

-1.3M

-9.5M

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 7. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-81M

320M

Iepriekšējā atvēršanas cena

8.56

Iepriekšējā slēgšanas cena

4.57

Ziņu noskaņojums

By Acuity

50%

50%

159 / 348 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

SIGA Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 20. apr. 23:49 UTC

Galvenie ziņu notikumi

New Zealand 1Q Inflation Higher Than Expected

2026. g. 20. apr. 23:10 UTC

Karstas akcijas

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

2026. g. 20. apr. 22:53 UTC

Galvenie tirgus virzītāji

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

2026. g. 20. apr. 23:45 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

2026. g. 20. apr. 23:44 UTC

Tirgus saruna

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

2026. g. 20. apr. 23:39 UTC

Tirgus saruna

Rio Tinto Posts Strong Start to Year -- Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Super Retail's Earnings Outlook Less Rosy -- Market Talk

2026. g. 20. apr. 23:09 UTC

Tirgus saruna

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

2026. g. 20. apr. 22:31 UTC

Iegādes, apvienošanās, pārņemšana

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026. g. 20. apr. 22:26 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Aims for Acquisition to Be Completed by End-2026

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Acquisition Would Be for A$175 Million

2026. g. 20. apr. 22:24 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

2026. g. 20. apr. 22:15 UTC

Iegādes, apvienošanās, pārņemšana

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026. g. 20. apr. 22:01 UTC

Iegādes, apvienošanās, pārņemšana

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

2026. g. 20. apr. 21:38 UTC

Tirgus saruna

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

2026. g. 20. apr. 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

2026. g. 20. apr. 21:24 UTC

Tirgus saruna

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

2026. g. 20. apr. 21:24 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 20. apr. 21:13 UTC

Peļņas

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

2026. g. 20. apr. 21:10 UTC

Peļņas

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

2026. g. 20. apr. 21:09 UTC

Peļņas

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

2026. g. 20. apr. 21:08 UTC

Peļņas

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

2026. g. 20. apr. 21:07 UTC

Peļņas

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

2026. g. 20. apr. 21:05 UTC

Peļņas

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

2026. g. 20. apr. 21:05 UTC

Peļņas

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Salīdzinājums

Cenas izmaiņa

SIGA Technologies Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.41 / 5.63Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

159 / 348 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
help-icon Live chat